Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127588202 | 12758820 | 2 | F | 20160831 | 20160926 | 20160919 | 20160928 | EXP | PHHY2016PA126749 | NOVARTIS | 89.76 | YR | F | Y | 0.00000 | 20160928 | CN | COUNTRY NOT SPECIFIED | PA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127588202 | 12758820 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 13.3 MG, QD PATCH 15 (CM2) | 22083 | 13.3 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | ||||||
| 127588202 | 12758820 | 2 | C | EUTEBROL | 2 | Unknown | U | 0 | |||||||||||
| 127588202 | 12758820 | 3 | C | ALOPURINOL | ALLOPURINOL | 1 | Unknown | U | 0 | ||||||||||
| 127588202 | 12758820 | 4 | C | HALOPERIDOL. | HALOPERIDOL | 1 | 0 | ||||||||||||
| 127588202 | 12758820 | 5 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 | ||||||||||||
| 127588202 | 12758820 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 127588202 | 12758820 | 7 | C | CALCIUM | CALCIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127588202 | 12758820 | 1 | Dementia Alzheimer's type |
| 127588202 | 12758820 | 2 | Product used for unknown indication |
| 127588202 | 12758820 | 3 | Product used for unknown indication |
| 127588202 | 12758820 | 4 | Product used for unknown indication |
| 127588202 | 12758820 | 5 | Product used for unknown indication |
| 127588202 | 12758820 | 6 | Product used for unknown indication |
| 127588202 | 12758820 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127588202 | 12758820 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127588202 | 12758820 | Blood cholesterol increased | |
| 127588202 | 12758820 | Blood triglycerides increased | |
| 127588202 | 12758820 | Constipation | |
| 127588202 | 12758820 | Dizziness | |
| 127588202 | 12758820 | Dysstasia | |
| 127588202 | 12758820 | Gait disturbance | |
| 127588202 | 12758820 | Hypertension | |
| 127588202 | 12758820 | Hypoaesthesia | |
| 127588202 | 12758820 | Speech disorder | |
| 127588202 | 12758820 | Transient ischaemic attack | |
| 127588202 | 12758820 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |